次世代シーケンシング(NGS)の世界市場2024年-2030年:市場規模、シェア、動向分析

◆英語タイトル:Next Generation Sequencing Market Size, Share & Trends Analysis Report By Technology (WGS, Targeted Sequencing & Resequencing), By Product (Platform, Consumables), By Application, By Workflow, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Grand View Researchが発行した調査報告書(GRV24JAN048)◆商品コード:GRV24JAN048
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2023年11月
◆ページ数:300
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,360,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

次世代シーケンシング(NGS)市場の成長と動向
Grand View Research, Inc.の最新レポートによると、次世代シーケンシングの世界市場規模は、2024年から2030年にかけて21.12%のCAGRを記録し、2030年までに312億6000万ドルに達すると予測されています。次世代シーケンシング(NGS)は、スケーラビリティ、超大容量、高速で全ゲノムの塩基配列を確立できる並列処理技術です。さらに、ヘルスケア業界では、NGSが医療検査研究、スクリーニング、疾病診断に徐々に取り入れられています。個別化医療では、創薬研究プロセスを加速するために頻繁に利用されています。

RNAシーケンシング、全ゲノムシーケンシング、全エクソーム・ターゲットシーケンシングなど、さまざまな可能性を秘めたシーケンシング手法が、包括的なサンプル分析を得るために研究者によって盛んに利用されています。従来のサンガーシーケンシング技術と比較すると、NGSは安価で、DNAシーケンシングのスループットが高いです。プレシークエンシングプロトコル、ポストシークエンシングプロトコル、データ解析の自動化が進んでいることも、NGS市場にプラスの影響を与えると予測されています。遺伝子レベルでの医学的分析による個別化医療開発のための新規プラットフォームの活用も重要な要因であり、予測期間中にNGSの需要を高めると予想されます。

そのほかにも、個別化医療やコンパニオン診断の発展、クラウドコンピューティングの進展、データ統合など、シーケンシング業界で見られる重要な成長トレンドがあります。さらに、ゲノムおよびプロテオミクスデータが容易に入手できるようになったことで、この市場は予測期間中に潜在的に価値の高い成長の道筋と機会を示すようになりました。また、世界的ながん罹患率の増加や高度な医療施設の利用可能性も、市場の成長を後押ししています。GLOBOCAN 2020によると、2020年の新規がん患者数は1,92,92,789人で、2040年には2,88,87,940人に増加すると予想されています。このようながん患者数の大幅な増加は、最終的にNGS市場の成長を加速させるがん研究を活性化させると推定されます。

NGS診断技術は、ウイルスのゲノム配列を決定し、突然変異の理解において科学者を支援する可能性を秘めています。さらに、COVID-19の流行を通じて、世界中の政府が企業セクターと協力し、実行可能な診断ツールとしてNGS技術を市場に導入しています。米国食品医薬品局は2020年6月、次世代シーケンシング技術を用いた最初のCOVID-19診断について、Illumina Inc.に緊急使用許可を与えた。SARS-CoV-2 RNAの定性同定のためのイルミナCOVIDSeqテストはFDAに承認されました。その結果、パンデミック時には次世代シーケンシング(NGS)技術の利用が増加すると予測されます。

次世代シーケンシング(NGS)市場レポートハイライト

- アプリケーション別では、腫瘍学セグメントが2023年に27.31%の最大の売上シェアを占めました。このセグメントの成長は、がんの有病率の増加とシーケンシング技術の進歩に顕著に起因しています。

- 学術研究セグメントは、これらの研究機関におけるアプリケーションベースの利用の増加と腫瘍学研究の増加により、予測期間中に大きく成長すると予想されます。また、治療薬、腫瘍学、ゲノム研究のための研究開発の進展が市場の成長につながりました。

- アジア太平洋地域では、医療インフラの広範な発展、先進技術の導入に対する各国の積極的な取り組み、主要企業の存在などにより、予測期間中に市場は大幅に成長するとみられます。

- 北米は2023年に49.35%のシェアで市場を支配しました。高い研究開発投資が存在し、技術的に先進的なヘルスケア研究の枠組みが利用可能であるため、この地域におけるWGSの開発も予測期間を通じて北米NGS市場の成長の重要な要因として機能すると予想されます。

第1章 調査方法と調査範囲
1.1 調査範囲
1.1.1 推計と予測タイムライン
1.2 調査方法
1.3 情報収集
1.3.1 購入データベース
1.3.2 Gvrの社内データベース
1.3.3 一次調査
1.3.4 一次調査の詳細
1.3.4.1 一次インタビュー: 統計
1.3.4.1.1 一次インタビューの地域分布
1.4 情報またはデータ分析
1.4.1 データ分析モデル
1.5 市場の形成と検証
1.6 目標
1.6.1 目的1
1.6.2 目的2
第2章 エグゼクティブサマリー
2.1 市場スナップショット
2.2 セグメント別スナップショット
2.3 競争状況スナップショット
第3章 市場変数、動向、範囲
3.1 市場系統の展望
3.1.1 親市場の展望
3.1.2 関連/補助市場の展望
3.2 コスト構造分析
3.3 ユーザー視点分析
3.3.1 消費者行動分析
3.3.1.1 市場インフルエンサー分析
3.4 手技コスト分析
3.5 主要エンドユーザー一覧
3.5.1 タイプ別
3.5.2 製品別
3.5.3 米国州別
3.6 技術概要
3.6.1 技術年表
3.7 Covid-19パンデミックの影響
3.7.1 サプライチェーンへの影響
3.7.2 Covid-19とNgsの関連性
3.8 市場動向と展望
3.9 市場セグメンテーションと範囲
3.10 市場ダイナミクス
3.10.1 市場促進要因分析
3.10.1.1 遺伝子配列決定コストの指数関数的低下
3.10.1.2 コンパニオン診断と個別化医療の発展
3.10.1.3 著名な市場企業間の競争の激化
3.10.1.4 Ngs技術の臨床的機会の増加
3.10.1.5 クラウドコンピューティングとデータ統合の技術的進歩
3.10.1.6 癌の効果的な診断・治療法の開発を支える医療費の増大
3.10.1.7 癌の有病率の増加
3.10.2 市場阻害要因分析
3.10.2.1 データ管理のための計算効率の欠如
3.10.2.2 価値に基づかないNgs償還政策と規制の現状
3.10.2.3 Ngs導入に伴う課題
3.11 ビジネス環境分析
3.11.1 要因別(政治・法律、経済、技術)スウォット分析
3.11.2 ポーターのファイブフォース分析
3.12 主要取引と戦略的提携分析
3.12.1 ジョイントベンチャー
3.12.2 合併・買収
3.12.3 ライセンス供与とパートナーシップ
3.12.4 技術提携
第4章 テクノロジービジネス分析
4.1 次世代シーケンシング(NGS)市場: 技術動向分析
4.2 ターゲットシーケンシング・リシーケンシング
4.2.1 ターゲットシーケンシング&リシーケンシング市場の動向・予測、2018年~2030年(百万米ドル)
4.2.1.1 DNAベースのターゲットシーケンシング&リシーケンシング
4.2.1.1.1 DNAベースのターゲットシーケンシング&リシーケンシング市場の動向・予測、2018年~2030年(百万米ドル)
4.2.1.2 RNAベースのターゲットシーケンシング&リシーケンシング
4.2.1.2.1 RNAベースのターゲットシーケンシング&リシーケンシング市場の動向・予測、2018年~2030年(百万米ドル)
4.3 全ゲノムシーケンシング
4.3.1 全ゲノムシーケンシング市場の動向・予測、2018年~2030年(百万米ドル)
4.4 ホールエクソームシーケンシング
4.4.1 ホールエクソームシーケンシング市場の動向・予測、2018年〜2030年(百万米ドル)
4.5 その他
4.5.1 その他市場の動向・予測、2018年〜2030年(百万米ドル)
第5章 製品ビジネス分析
5.1 次世代シーケンシング(NGS)市場 製品動向分析
5.2 プラットフォーム
5.2.1 プラットフォーム市場の動向・予測、2018年~2030年(百万米ドル)
5.2.1.1 シークエンシング
5.2.1.1.1 シークエンシングプラットフォーム市場の動向・予測、2018年~2030年(百万米ドル)
5.2.1.2 データ解析
5.2.1.2.1 データ解析プラットフォーム市場の動向・予測、2018年~2030年(百万米ドル)
5.3 消耗品
5.3.1 消耗品市場の動向・予測、2018年~2030年(百万米ドル)
5.3.2 サンプル前処理
5.3.2.1 サンプル前処理市場の動向・予測、2018年~2030年(百万米ドル)
5.3.3 ターゲット濃縮
5.3.3.1 ターゲット濃縮市場の動向・予測、2018年~2030年(百万米ドル)
5.3.4 その他
5.3.4.1 その他市場の動向・予測、2018年〜2030年(百万米ドル)
第6章 アプリケーションビジネス分析
6.1 次世代シーケンシング(NGS)市場 アプリケーション動向分析
6.2 がん領域
6.2.1 オンコロジー市場の動向・予測、2018年~2030年(百万米ドル)
6.2.2 診断とスクリーニング
6.2.2.1 診断&スクリーニング市場の動向・予測、2018〜2030年(百万米ドル)
6.2.2.2 腫瘍スクリーニング
6.2.2.2.1 腫瘍スクリーニング市場の動向・予測、2018年〜2030年(百万米ドル)
6.2.2.2.2 散発性がんスクリーニング市場の動向・予測、2018年〜2030年(百万米ドル)
6.2.2.2.3 遺伝性がんスクリーニング市場の動向・予測、2018年〜2030年(百万米ドル)
6.2.2.3 コンパニオン診断薬
6.2.2.3.1 コンパニオン診断薬市場の動向・予測、2018年〜2030年(百万米ドル)
6.2.2.4 その他の診断薬
6.2.2.4.1 その他の診断薬市場の動向・予測、2018年~2030年(百万米ドル)
6.2.3 調査研究
6.2.3.1 調査研究市場の動向・予測、2018年〜2030年(百万米ドル)
6.3 臨床調査
6.3.1 臨床調査市場の動向・予測、2018年〜2030年(百万米ドル)
6.3.2 感染症
6.3.2.1 感染症市場の動向・予測、2018年〜2030年(百万米ドル)
6.3.3 特発性疾患
6.3.3.1 特発性疾患市場の動向・予測、2018年〜2030年(百万米ドル)
6.3.4 遺伝性疾患
6.3.4.1 2018〜2030年の遺伝性疾患市場の動向・予測(百万米ドル)
6.3.5 非感染性/その他の疾患
6.3.5.1 非感染性/その他の疾患市場の動向・予測、2018年〜2030年(百万米ドル)
6.4 リプロダクティブヘルス
6.4.1 リプロダクティブヘルス市場の動向・予測、2018年〜2030年(百万米ドル)
6.4.2 ニップト
6.4.2.1 ニップト市場の動向・予測、2018年〜2030年(百万米ドル)
6.4.2.2 異数性
6.4.2.2.1 異数性市場の動向・予測、2018年〜2030年(百万米ドル)
6.4.2.3 微小欠失
6.4.2.3.1 微小欠失市場の動向・予測、2018年~2030年(百万米ドル)
6.4.3 Pgt
6.4.3.1 Pgt市場の動向・予測、2018年~2030年(百万米ドル)
6.4.4 新生児遺伝子スクリーニング
6.4.4.1 新生児遺伝子スクリーニング市場の動向・予測、2018年〜2030年(百万米ドル)
6.4.5 単一遺伝子解析
6.4.5.1 単一遺伝子解析市場の動向・予測、2018年〜2030年(百万米ドル)
6.5 Hlaタイピング/免疫系モニタリング
6.5.1 Hlaタイピング/免疫系モニタリング市場の動向・予測、2018年〜2030年(百万米ドル)
6.6 メタゲノミクス、疫学、医薬品開発
6.6.1 メタゲノミクス、疫学&医薬品開発市場の動向・予測、2018年〜2030年(百万米ドル)
6.7 アグリゲノミクスと科学捜査
6.7.1 アグリゲノミクス&科学捜査市場の動向・予測、2018年~2030年(百万米ドル)
6.8 消費者ゲノム
6.8.1 コンシューマーゲノミクス市場の動向・予測、2018年〜2030年(百万米ドル)
第7章 ワークフロー事業分析
7.1 次世代シーケンシング(NGS)市場 ワークフロー動向分析
7.2 プレシーケンシング
7.2.1 プレシーケンシング市場の動向・予測、2018年~2030年(百万米ドル)
7.2.1.1 Ngsライブラリー調製キット
7.2.1.1.1 Ngsライブラリー調製キット市場の動向・予測、2018年〜2030年(百万米ドル)
7.2.1.2 半自動ライブラリー調製
7.2.1.2.1 半自動ライブラリー調製市場の動向・予測、2018年~2030年(百万米ドル)
7.2.1.3 自動ライブラリー調製
7.2.1.3.1 自動ライブラリー調製市場の動向・予測、2018年~2030年(百万米ドル)
7.3 シーケンシング
7.3.1 シークエンシング市場の動向・予測、2018年〜2030年(百万米ドル)
7.4 データ解析
7.4.1 データ解析市場の動向・予測、2018年〜2030年(百万米ドル)
7.4.2 一次データ解析
7.4.2.1 一次データ分析市場の動向・予測、2018年~2030年(百万米ドル)
7.4.3 セカンダリーデータ分析
7.4.3.1 二次データ分析市場の動向・予測、2018年~2030年(百万米ドル)
7.4.4 三次データ分析
7.4.4.1 三次データ分析市場の動向・予測、2018年~2030年(百万米ドル)
第8章 エンドユースビジネス分析
8.1 次世代シーケンシング(NGS)市場 エンドユーザー動向分析
8.2 学術研究
8.2.1 学術研究市場の予測・動向、2018年~2030年(百万米ドル)
8.3 臨床研究
8.3.1 臨床研究市場の動向・予測、2018年〜2030年(百万米ドル)
8.4 病院・診療所
8.4.1 病院・診療所市場の動向・予測、2018年〜2030年(百万米ドル)
8.5 製薬・バイオテクノロジー企業
8.5.1 製薬・バイオテクノロジー企業市場の動向・予測、2018年〜2030年(百万米ドル)
8.6 その他のユーザー
8.6.1 その他のユーザー市場の動向・予測、2018年~2030年(百万米ドル)
第9章 次世代シーケンシング(NGS)市場:製品、技術、用途、ワークフロー、エンドユーザー別の地域別推定と動向分析
9.1 北米
9.1.1 北米のNgs市場の動向・予測、2018年〜2030年(百万米ドル)
9.1.2 米国
9.1.2.1 主要国のダイナミクス
9.1.2.2 対象疾患の有病率
9.1.2.3 競争シナリオ
9.1.2.4 規制の枠組み
9.1.2.5 保険償還シナリオ
9.1.2.6 米国のNgs市場予測・動向、2018年~2030年(百万米ドル)
9.1.3 カナダ
9.1.3.1 主要国のダイナミクス
9.1.3.2 対象疾患の有病率
9.1.3.3 競争シナリオ
9.1.3.4 規制の枠組み
9.1.3.5 保険償還シナリオ
9.1.3.6 カナダのNgs市場予測・動向、2018年~2030年(百万米ドル)
9.2 欧州
9.2.1 欧州のNgs市場の動向・予測、2018年〜2030年(百万米ドル)
9.2.2 ウク
9.2.2.1 主要国のダイナミクス
9.2.2.2 対象疾患の有病率
9.2.2.3 競争シナリオ
9.2.2.4 規制の枠組み
9.2.2.5 保険償還シナリオ
9.2.2.6 ウクライナNgs市場予測・動向、2018年~2030年(百万米ドル)
9.2.3 ドイツ
9.2.3.1 主要国のダイナミクス
9.2.3.2 対象疾患の有病率
9.2.3.3 競争シナリオ
9.2.3.4 規制の枠組み
9.2.3.5 保険償還シナリオ
9.2.3.6 ドイツのNgs市場予測・動向、2018年~2030年(百万米ドル)
9.2.4 フランス
9.2.4.1 主要国のダイナミクス
9.2.4.2 対象疾患の有病率
9.2.4.3 競争シナリオ
9.2.4.4 規制の枠組み
9.2.4.5 保険償還シナリオ
9.2.4.6 フランス Ngs市場予測・動向、2018年~2030年 (百万米ドル)
9.2.5 スペイン
9.2.5.1 主要国のダイナミクス
9.2.5.2 競争シナリオ
9.2.5.3 規制の枠組み
9.2.5.4 保険償還シナリオ
9.2.5.5 スペインのNgs市場予測・動向、2018年~2030年(百万米ドル)
9.2.6 イタリア
9.2.6.1 主要国のダイナミクス
9.2.6.2 対象疾患の有病率
9.2.6.3 競争シナリオ
9.2.6.4 規制の枠組み
9.2.6.5 保険償還シナリオ
9.2.6.6 イタリアのNgs市場予測・動向、2018年~2030年(百万米ドル)
9.2.7 デンマーク
9.2.7.1 主要国の動向
9.2.7.2 対象疾患の有病率
9.2.7.3 競争シナリオ
9.2.7.4 規制の枠組み
9.2.7.5 保険償還シナリオ
9.2.7.6 デンマーク Ngs市場予測・動向、2018年~2030年 (百万米ドル)
9.2.8 スウェーデン
9.2.8.1 主要国の動向
9.2.8.2 対象疾患の有病率
9.2.8.3 競争シナリオ
9.2.8.4 規制の枠組み
9.2.8.5 保険償還シナリオ
9.2.8.6 スウェーデン Ngs市場予測・動向、2018年~2030年 (百万米ドル)
9.2.9 ノルウェー
9.2.9.1 主要国の動向
9.2.9.2 対象疾患の有病率
9.2.9.3 競争シナリオ
9.2.9.4 規制の枠組み
9.2.9.5 保険償還シナリオ
9.2.9.6 ノルウェーのNgs市場予測・動向、2018年~2030年 (百万米ドル)
9.3 アジア太平洋地域
9.3.1 アジア太平洋地域のNgs市場の動向・予測、2018年~2030年(百万米ドル)
9.3.2 日本
9.3.2.1 主要国のダイナミクス
9.3.2.2 対象疾患の有病率
9.3.2.3 競争シナリオ
9.3.2.4 規制の枠組み
9.3.2.5 保険償還シナリオ
9.3.2.6 日本のNgs市場の動向・予測、2018年〜2030年(百万米ドル)
9.3.3 中国
9.3.3.1 主要国のダイナミクス
9.3.3.2 ターゲット疾患の有病率
9.3.3.3 競争シナリオ
9.3.3.4 規制の枠組み
9.3.3.5 保険償還シナリオ
9.3.3.6 中国Ngs市場の動向・予測、2018年~2030年(百万米ドル)
9.3.4 インド
9.3.4.1 主要国のダイナミクス
9.3.4.2 対象疾患の有病率
9.3.4.3 競争シナリオ
9.3.4.4 規制の枠組み
9.3.4.5 保険償還シナリオ
9.3.4.6 インドのNgs市場予測・動向、2018年~2030年(百万米ドル)
9.3.5 オーストラリア
9.3.5.1 主要国のダイナミクス
9.3.5.2 対象疾患の有病率
9.3.5.3 競争シナリオ
9.3.5.4 規制の枠組み
9.3.5.5 保険償還シナリオ
9.3.5.6 オーストラリアのNgs市場予測・動向、2018年~2030年(百万米ドル)
9.3.6 タイ
9.3.6.1 主要国のダイナミクス
9.3.6.2 対象疾患の有病率
9.3.6.3 競争シナリオ
9.3.6.4 規制の枠組み
9.3.6.5 保険償還シナリオ
9.3.6.6 タイ Ngs市場予測・動向、2018年~2030年 (百万米ドル)
9.3.7 韓国
9.3.7.1 主要国のダイナミクス
9.3.7.2 対象疾患の有病率
9.3.7.3 競争シナリオ
9.3.7.4 規制の枠組み
9.3.7.5 保険償還シナリオ
9.3.7.6 韓国のNgs市場予測・動向、2018年~2030年(百万米ドル)
9.4 中南米
9.4.1 中南米のNgs市場の動向・予測、2018年~2030年(百万米ドル)
9.4.2 ブラジル
9.4.2.1 主要国のダイナミクス
9.4.2.2 対象疾患の有病率
9.4.2.3 競争シナリオ
9.4.2.4 規制の枠組み
9.4.2.5 保険償還シナリオ
9.4.2.6 ブラジルのNgs市場予測・動向、2018年~2030年 (百万米ドル)
9.4.3 メキシコ
9.4.3.1 主要国のダイナミクス
9.4.3.2 対象疾患の有病率
9.4.3.3 競争シナリオ
9.4.3.4 規制の枠組み
9.4.3.5 保険償還シナリオ
9.4.3.6 メキシコのNgs市場予測・動向、2018年~2030年(百万米ドル)
9.4.4 アルゼンチン
9.4.4.1 主要国のダイナミクス
9.4.4.2 対象疾患の有病率
9.4.4.3 規制の枠組み
9.4.4.4 保険償還シナリオ
9.4.4.5 アルゼンチンのNgs市場予測・動向、2018年~2030年 (百万米ドル)
9.5 MEA
9.5.1 MEAのNgs市場予測・動向、2018年~2030年(百万米ドル)
9.5.2 南アフリカ
9.5.2.1 主要国の動向
9.5.2.2 対象疾患の有病率
9.5.2.3 競争シナリオ
9.5.2.4 規制の枠組み
9.5.2.5 保険償還シナリオ
9.5.2.6 南アフリカのNgs市場予測・動向、2018年~2030年(百万米ドル)
9.5.3 サウジアラビア
9.5.3.1 主要国の動向
9.5.3.2 対象疾患の有病率
9.5.3.3 競争シナリオ
9.5.3.4 規制の枠組み
9.5.3.5 保険償還シナリオ
9.5.3.6 サウジアラビアのNgs市場予測・動向、2018年~2030年 (百万米ドル)
9.5.4 アラブ首長国連邦
9.5.4.1 主要国の動向
9.5.4.2 対象疾患の有病率
9.5.4.3 競争シナリオ
9.5.4.4 規制の枠組み
9.5.4.5 保険償還シナリオ
9.5.4.6 アラブ首長国連邦のNgs市場予測・動向、2018年~2030年 (百万米ドル)
9.5.5 クウェート
9.5.5.1 主要国の動向
9.5.5.2 対象疾患の有病率
9.5.5.3 競争シナリオ
9.5.5.4 規制の枠組み
9.5.5.5 保険償還シナリオ
9.5.5.6 クウェートのNgs市場予測・動向、2018年~2030年(百万米ドル)
第10章 競争状況

❖ レポートの目次 ❖

Table of Contents

Chapter 1 Methodology And Scope
1.1 Research Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Primary Research
1.3.4 Details Of Primary Research
1.3.4.1 Primary Interviews: Statistics
1.3.4.1.1 Geographical Distribution Of Primary Interviews
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Objectives
1.6.1 Objective 1
1.6.2 Objective 2
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Cost Structure Analysis
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.1.1 Market Influencer Analysis
3.4 Procedure Cost Analysis
3.5 List Of Key End Users
3.5.1 By Type
3.5.2 By Product
3.5.3 By U.S. State
3.6 Technology Overview
3.6.1 Technology Timeline
3.7 Impact Of Covid-19 Pandemic
3.7.1 Impact On The Supply Chain
3.7.2 Association Of Covid-19 With Ngs
3.8 Market Trends And Outlook
3.9 Market Segmentation And Scope
3.10 Market Dynamics
3.10.1 Market Driver Analysis
3.10.1.1 Exponentially Decreasing Costs For Genetic Sequencing
3.10.1.2 Development Of Companion Diagnostics And Personalized Medicine
3.10.1.3 Rise In Competition Among Prominent Market Entities
3.10.1.4 Rising Clinical Opportunity For Ngs Technology
3.10.1.5 Technological Advancements In Cloud Computing And Data Integration
3.10.1.6 Growing Healthcare Expenditure Supporting Development Of Effective Diagnostic & Therapeutic Procedures For Cancer
3.10.1.7 Increasing Prevalence Of Cancer
3.10.2 Market Restraint Analysis
3.10.2.1 Lack Of Computational Efficiency For Data Management
3.10.2.2 Non–Value-Based Ngs Reimbursement Policy And Regulation Status
3.10.2.3 Challenges Associated With Ngs Implementation
3.11 Business Environment Analysis
3.11.1 Swot Analysis; By Factor (Political & Legal, Economic, And Technological)
3.11.2 Porter’s Five Forces Analysis
3.12 Major Deals And Strategic Alliances Analysis
3.12.1 Joint Ventures
3.12.2 Mergers & Acquisitions
3.12.3 Licensing & Partnerships
3.12.4 Technology Collaborations
Chapter 4 Technology Business Analysis
4.1 Next Generation Sequencing Market: Technology Movement Analysis
4.2 Targeted Sequencing & Resequencing
4.2.1 Targeted Sequencing & Resequencing Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.2.1.1 Dna-Based Targeted Sequencing & Resequencing
4.2.1.1.1 Dna-Based Targeted Sequencing & Resequencing Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.2.1.2 Rna-Based Targeted Sequencing & Resequencing
4.2.1.2.1 Rna -Based Targeted Sequencing & Resequencing Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.3 Whole Genome Sequencing
4.3.1 Whole Genome Sequencing Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.4 Whole Exome Sequencing
4.4.1 Whole Exome Sequencing Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.5 Others
4.5.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 5 Product Business Analysis
5.1 Next Generation Sequencing Market: Product Movement Analysis
5.2 Platforms
5.2.1 Platforms Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.2.1.1 Sequencing
5.2.1.1.1 Sequencing Platforms Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.2.1.2 Data Analysis
5.2.1.2.1 Data Analysis Platforms Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.3 Consumables
5.3.1 Consumables Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.3.2 Sample Preparation
5.3.2.1 Sample Preparation Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.3.3 Target Enrichment
5.3.3.1 Target Enrichment Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.3.4 Others
5.3.4.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 6 Application Business Analysis
6.1 Next Generation Sequencing Market: Application Movement Analysis
6.2 Oncology
6.2.1 Oncology Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.2.2 Diagnostics & Screening
6.2.2.1 Diagnostics & Screening Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.2.2.2 Oncology Screening
6.2.2.2.1 Oncology Screening Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.2.2.2.2 Sporadic Cancer Screening Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.2.2.2.3 Inherited Cancer Screening Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.2.2.3 Companion Diagnostics
6.2.2.3.1 Companion Diagnostics Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.2.2.4 Other Diagnostics
6.2.2.4.1 Other Diagnostics Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.2.3 Research Studies
6.2.3.1 Research Studies Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.3 Clinical Investigation
6.3.1 Clinical Investigation Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.3.2 Infectious Diseases
6.3.2.1 Infectious Diseases Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.3.3 Idiopathic Diseases
6.3.3.1 Idiopathic Diseases Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.3.4 Inherited Diseases
6.3.4.1 Inherited Diseases Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.3.5 Non-Communicable/Other Diseases
6.3.5.1 Non-Communicable/Other Diseases Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4 Reproductive Health
6.4.1 Reproductive Health Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4.2 Nipt
6.4.2.1 Nipt Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4.2.2 Aneuploidy
6.4.2.2.1 Aneuploidy Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4.2.3 Microdeletions
6.4.2.3.1 Microdeletions Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4.3 Pgt
6.4.3.1 Pgt Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4.4 Newborn Genetic Screening
6.4.4.1 Newborn Genetic Screening Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4.5 Single Gene Analysis
6.4.5.1 Single Gene Analysis Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.5 Hla Typing/Immune System Monitoring
6.5.1 Hla Typing/Immune System Monitoring Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.6 Metagenomics, Epidemiology & Drug Development
6.6.1 Metagenomics, Epidemiology & Drug Development Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.7 Agrigenomics & Forensics
6.7.1 Agrigenomics & Forensics Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.8 Consumer Genomics
6.8.1 Consumer Genomics Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 7 Workflow Business Analysis
7.1 Next Generation Sequencing Market: Workflow Movement Analysis
7.2 Presequencing
7.2.1 Pre-Sequencing Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.2.1.1 Ngs Library Preparation Kits
7.2.1.1.1 Ngs Library Preparation Kits Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.2.1.2 Semiautomated Library Preparation
7.2.1.2.1 Semiautomated Library Preparation Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.2.1.3 Automated Library Preparation
7.2.1.3.1 Automated Library Preparation Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.3 Sequencing
7.3.1 Sequencing Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.4 Data Analysis
7.4.1 Data Analysis Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.4.2 Primary Data Ngs Analysis
7.4.2.1 Primary Data Analysis Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.4.3 Secondary Data Analysis
7.4.3.1 Secondary Data Analysis Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.4.4 Tertiary Data Analysis
7.4.4.1 Tertiary Data Analysis Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 8 End-Use Business Analysis
8.1 Next Generation Sequencing Market: End-Use Movement Analysis
8.2 Academic Research
8.2.1 Academic Research Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.3 Clinical Research
8.3.1 Clinical Research Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.4 Hospitals & Clinics
8.4.1 Hospitals & Clinics Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.5 Pharmaceutical & Biotech Entities
8.5.1 Pharmaceutical & Biotech Entities Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.6 Other Users
8.6.1 Other Users Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 9 Next Generation Sequencing Market: Regional Estimates And Trend Analysis, By Product, Technology, Application, Workflow, & End-Use
9.1 North America
9.1.1 North America Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.1.2 U.S.
9.1.2.1 Key Country Dynamics
9.1.2.2 Target Disease Prevalence
9.1.2.3 Competitive Scenario
9.1.2.4 Regulatory Framework
9.1.2.5 Reimbursement Scenario
9.1.2.6 U.S. Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.1.3 Canada
9.1.3.1 Key Country Dynamics
9.1.3.2 Target Disease Prevalence
9.1.3.3 Competitive Scenario
9.1.3.4 Regulatory Framework
9.1.3.5 Reimbursement Scenario
9.1.3.6 Canada Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2 Europe
9.2.1 Europe Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2.2 Uk
9.2.2.1 Key Country Dynamics
9.2.2.2 Target Disease Prevalence
9.2.2.3 Competitive Scenario
9.2.2.4 Regulatory Framework
9.2.2.5 Reimbursement Scenario
9.2.2.6 Uk Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2.3 Germany
9.2.3.1 Key Country Dynamics
9.2.3.2 Target Disease Prevalence
9.2.3.3 Competitive Scenario
9.2.3.4 Regulatory Framework
9.2.3.5 Reimbursement Scenario
9.2.3.6 Germany Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2.4 France
9.2.4.1 Key Country Dynamics
9.2.4.2 Target Disease Prevalence
9.2.4.3 Competitive Scenario
9.2.4.4 Regulatory Framework
9.2.4.5 Reimbursement Scenario
9.2.4.6 France Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2.5 Spain
9.2.5.1 Key Country Dynamics
9.2.5.2 Competitive Scenario
9.2.5.3 Regulatory Framework
9.2.5.4 Reimbursement Scenario
9.2.5.5 Spain Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2.6 Italy
9.2.6.1 Key Country Dynamics
9.2.6.2 Target Disease Prevalence
9.2.6.3 Competitive Scenario
9.2.6.4 Regulatory Framework
9.2.6.5 Reimbursement Scenario
9.2.6.6 Italy Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2.7 Denmark
9.2.7.1 Key Country Dynamics
9.2.7.2 Target Disease Prevalence
9.2.7.3 Competitive Scenario
9.2.7.4 Regulatory Framework
9.2.7.5 Reimbursement Scenario
9.2.7.6 Denmark Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2.8 Sweden
9.2.8.1 Key Country Dynamics
9.2.8.2 Target Disease Prevalence
9.2.8.3 Competitive Scenario
9.2.8.4 Regulatory Framework
9.2.8.5 Reimbursement Scenario
9.2.8.6 Sweden Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2.9 Norway
9.2.9.1 Key Country Dynamics
9.2.9.2 Target Disease Prevalence
9.2.9.3 Competitive Scenario
9.2.9.4 Regulatory Framework
9.2.9.5 Reimbursement Scenario
9.2.9.6 Norway Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.3 Asia Pacific
9.3.1 Asia Pacific Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.3.2 Japan
9.3.2.1 Key Country Dynamics
9.3.2.2 Target Disease Prevalence
9.3.2.3 Competitive Scenario
9.3.2.4 Regulatory Framework
9.3.2.5 Reimbursement Scenario
9.3.2.6 Japan Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.3.3 China
9.3.3.1 Key Country Dynamics
9.3.3.2 Target Disease Prevalence
9.3.3.3 Competitive Scenario
9.3.3.4 Regulatory Framework
9.3.3.5 Reimbursement Scenario
9.3.3.6 China Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.3.4 India
9.3.4.1 Key Country Dynamics
9.3.4.2 Target Disease Prevalence
9.3.4.3 Competitive Scenario
9.3.4.4 Regulatory Framework
9.3.4.5 Reimbursement Scenario
9.3.4.6 India Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.3.5 Australia
9.3.5.1 Key Country Dynamics
9.3.5.2 Target Disease Prevalence
9.3.5.3 Competitive Scenario
9.3.5.4 Regulatory Framework
9.3.5.5 Reimbursement Scenario
9.3.5.6 Australia Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.3.6 Thailand
9.3.6.1 Key Country Dynamics
9.3.6.2 Target Disease Prevalence
9.3.6.3 Competitive Scenario
9.3.6.4 Regulatory Framework
9.3.6.5 Reimbursement Scenario
9.3.6.6 Thailand Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.3.7 South Korea
9.3.7.1 Key Country Dynamics
9.3.7.2 Target Disease Prevalence
9.3.7.3 Competitive Scenario
9.3.7.4 Regulatory Framework
9.3.7.5 Reimbursement Scenario
9.3.7.6 South Korea Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.4 Latin America
9.4.1 Latin America Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.4.2 Brazil
9.4.2.1 Key Country Dynamics
9.4.2.2 Target Disease Prevalence
9.4.2.3 Competitive Scenario
9.4.2.4 Regulatory Framework
9.4.2.5 Reimbursement Scenario
9.4.2.6 Brazil Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.4.3 Mexico
9.4.3.1 Key Country Dynamics
9.4.3.2 Target Disease Prevalence
9.4.3.3 Competitive Scenario
9.4.3.4 Regulatory Framework
9.4.3.5 Reimbursement Scenario
9.4.3.6 Mexico Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.4.4 Argentina
9.4.4.1 Key Country Dynamics
9.4.4.2 Target Disease Prevalence
9.4.4.3 Regulatory Framework
9.4.4.4 Reimbursement Scenario
9.4.4.5 Argentina Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.5 MEA
9.5.1 MEA Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.5.2 South Africa
9.5.2.1 Key Country Dynamics
9.5.2.2 Target Disease Prevalence
9.5.2.3 Competitive Scenario
9.5.2.4 Regulatory Framework
9.5.2.5 Reimbursement Scenario
9.5.2.6 South Africa Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.5.3 Saudi Arabia
9.5.3.1 Key Country Dynamics
9.5.3.2 Target Disease Prevalence
9.5.3.3 Competitive Scenario
9.5.3.4 Regulatory Framework
9.5.3.5 Reimbursement Scenario
9.5.3.6 Saudi Arabia Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.5.4 UAE
9.5.4.1 Key Country Dynamics
9.5.4.2 Target Disease Prevalence
9.5.4.3 Competitive Scenario
9.5.4.4 Regulatory Framework
9.5.4.5 Reimbursement Scenario
9.5.4.6 UAE Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.5.5 Kuwait
9.5.5.1 Key Country Dynamics
9.5.5.2 Target Disease Prevalence
9.5.5.3 Competitive Scenario
9.5.5.4 Regulatory Framework
9.5.5.5 Reimbursement Scenario
9.5.5.6 Kuwait Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 10 Competitive Landscape
10.1 Company Categorization
10.2 Strategy Mapping
10.3 Company Market Share Analysis, 2023
10.4 Company Profiles
10.4.1 Thermo Fisher Scientific, Inc.
10.4.1.1 Company Overview
10.4.1.2 Life Technologies Corporation
10.4.1.2.1 Company Overview
10.4.1.3 Financial Performance
10.4.1.4 Product Benchmarking
10.4.1.5 Strategic Initiatives
10.4.2 Qiagen N.V.
10.4.2.1 Company Overview
10.4.2.2 Clc Bio
10.4.2.2.1 Company Overview
10.4.2.3 Financial Performance
10.4.2.4 Product Benchmarking
10.4.2.5 Strategic Initiatives
10.4.3 Illumina, Inc.
10.4.3.1 Company Overview
10.4.3.2 Edico Genome
10.4.3.2.1 Company Overview
10.4.3.3 Financial Performance
10.4.3.4 Product Benchmarking
10.4.3.5 Strategic Initiatives
10.4.4 F. Hoffmann-La Roche Ag
10.4.4.1 Company Overview
10.4.4.2 Foundation Medicine
10.4.4.2.1 Company Overview
10.4.4.3 Financial Performance
10.4.4.4 Product Benchmarking
10.4.4.5 Strategic Initiatives
10.4.5 Agilent Technologies, Inc.
10.4.5.1 Company Overview
10.4.5.2 Financial Performance
10.4.5.3 Product Benchmarking
10.4.5.4 Strategic Initiatives
10.4.6 Bio-Rad Laboratories, Inc.
10.4.6.1 Company Overview
10.4.6.2 Gnubio
10.4.6.2.1 Company Overview
10.4.6.3 Financial Performance
10.4.6.4 Product Benchmarking
10.4.6.5 Strategic Initiatives
10.4.7 Pieriandx
10.4.7.1 Company Overview
10.4.7.2 Tute Genomics
10.4.7.2.1 Company Overview
10.4.7.2.2 Knome, Inc.
10.4.7.2.2.1 Company Overview
10.4.7.3 Product Benchmarking
10.4.7.4 Strategic Initiatives
10.4.8 Oxford Nanopore Technologies Plc
10.4.8.1 Company Overview
10.4.8.2 Financial Performance
10.4.8.3 Product Benchmarking
10.4.8.4 Strategic Initiatives
10.4.9 Partek Incorporated
10.4.9.1 Company Overview
10.4.9.2 Product Benchmarking
10.4.9.3 Strategic Initiatives
10.4.10 Eurofins Scientific
10.4.10.1 Company Overview
10.4.10.2 Eurofins Gatc Biotech Gmbh
10.4.10.2.1 Company Overview
10.4.10.3 Financial Performance
10.4.10.4 Product Benchmarking
10.4.10.5 Strategic Initiatives
10.4.11 Dnastar
10.4.11.1 Company Overview
10.4.11.2 Product Benchmarking
10.4.11.3 Strategic Initiatives
10.4.12 Sophia Genetics.
10.4.12.1 Company Overview
10.4.12.2 Financial Performance
10.4.12.3 Product Benchmarking
10.4.12.4 Strategic Initiatives
10.4.13 Fabric Genomics, Inc.
10.4.13.1 Company Overview
10.4.13.2 Financial Performance
10.4.13.3 Product Benchmarking
10.4.13.4 Strategic Initiatives
10.4.14 Laboratory Corporation Of America
10.4.14.1 Company Overview
10.4.14.2 Financial Performance
10.4.14.3 Product Benchmarking
10.4.14.4 Strategic Initiatives
10.4.15 Syapse, Inc.
10.4.15.1 Company Overview
10.4.15.2 Product Benchmarking
10.4.15.3 Strategic Initiatives
10.4.16 Personalis, Inc.
10.4.16.1 Company Overview
10.4.16.2 Financial Performance
10.4.16.3 Product Benchmarking
10.4.16.4 Strategic Initiatives
10.4.17 10x Genomics
10.4.17.1 Company Overview
10.4.17.2 Financial Performance
10.4.17.3 Product Benchmarking
10.4.17.4 Strategic Initiatives
10.4.18 Dnanexus, Inc.
10.4.18.1 Company Overview
10.4.18.2 Product Benchmarking
10.4.18.3 Strategic Initiatives
10.4.19 Centogene N.V.
10.4.19.1 Company Overview
10.4.19.2 Financial Performance
10.4.19.3 Product Benchmarking
10.4.19.4 Strategic Initiatives
10.4.20 Invitae Corporation
10.4.20.1 Company Overview
10.4.20.2 Financial Performance
10.4.20.3 Product Benchmarking
10.4.20.4 Strategic Initiatives
10.4.21 Genedx, Llc
10.4.21.1 Company Overview
10.4.21.2 Financial Performance
10.4.21.3 Product Benchmarking
10.4.21.4 Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Country share estimation
Table 4 Healthcare expenditure
Table 5 NGS top platforms
Table 6 Base pairs sequenced using WGS, WES, and targeted sequencing & resequencing
Table 7 Clonal amplification products in the market
Table 8 North America next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 9 North America next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 10 North America next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 11 North America next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 12 North America NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 13 North America NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 14 North America next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 15 North America next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 16 North America targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 17 North America next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 18 North America NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 19 North America NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 20 North America next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 21 US next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 22 US next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 23 US next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 24 US next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 25 US NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 26 US NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 27 US next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 28 US next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 29 US targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 30 US next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 31 US NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 32 US NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 33 US next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 34 Canada next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 35 Canada next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 36 Canada next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 37 Canada next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 38 Canada NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 39 Canada NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 40 Canada next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 41 Canada next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 42 Canada targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 43 Canada next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 44 Canada NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 45 Canada NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 46 Canada next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 47 Europe next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 48 Europe next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 49 Europe next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 50 Europe next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 51 Europe NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 52 Europe NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 53 Europe next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 54 Europe next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 55 Europe targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 56 Europe next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 57 Europe NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 58 Europe NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 59 Europe next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 60 Germany next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 61 Germany next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 62 Germany next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 63 Germany next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 64 Germany NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 65 Germany NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 66 Germany next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 67 Germany next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 68 Germany targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 69 Germany next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 70 Germany NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 71 Germany NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 72 Germany next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 73 UK next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 74 UK next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 75 UK next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 76 UK next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 77 UK NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 78 UK NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 79 UK next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 80 UK next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 81 UK targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 82 UK next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 83 UK NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 84 UK NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 85 UK next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 86 Spain next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 87 Spain next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 88 Spain next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 89 Spain next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 90 Spain NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 91 Spain NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 92 Spain next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 93 Spain next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 94 Spain targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 95 Spain next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 96 Spain NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 97 Spain NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 98 Spain next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 99 France next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 100 France next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 101 France next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 102 France next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 103 France NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 104 France NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 105 France next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 106 France next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 107 France targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 108 France next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 109 France NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 110 France NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 111 France next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 112 Italy next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 113 Italy next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 114 Italy next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 115 Italy next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 116 Italy NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 117 Italy NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 118 Italy next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 119 Italy next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 120 Italy targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 121 Italy next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 122 Italy NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 123 Italy NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 124 Italy next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 125 Italy next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 126 Denmark next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 127 Denmark next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 128 Denmark next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 129 Denmark next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 130 Denmark NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 131 Denmark NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 132 Denmark next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 133 Denmark next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 134 Denmark targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 135 Denmark next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 136 Denmark NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 137 Denmark NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 138 Denmark next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 139 Norway next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 140 Norway next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 141 Norway next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 142 Norway next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 143 Norway NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 144 Norway NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 145 Norway next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 146 Norway next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 147 Norway targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 148 Norway next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 149 Norway NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 150 Norway NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 151 Norway next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 152 Sweden next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 153 Sweden next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 154 Sweden next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 155 Sweden next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 156 Sweden NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 157 Sweden NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 158 Sweden next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 159 Sweden next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 160 Sweden targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 161 Sweden next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 162 Sweden NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 163 Sweden NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 164 Sweden next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 165 Asia Pacific next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 166 Asia Pacific next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 167 Asia Pacific next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 168 Asia Pacific next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 169 Asia Pacific NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 170 Asia Pacific NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 171 Asia Pacific next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 172 Asia Pacific next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 173 Asia Pacific targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 174 Asia Pacific next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 175 Asia Pacific NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 176 Asia Pacific NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 177 Asia Pacific next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 178 Japan next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 179 Japan next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 180 Japan next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 181 Japan next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 182 Japan NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 183 Japan NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 184 Japan next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 185 Japan next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 186 Japan targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 187 Japan next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 188 Japan NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 189 Japan NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 190 Japan next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 191 China next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 192 China next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 193 China next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 194 China next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 195 China NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 196 China NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 197 China next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 198 China next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 199 China targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 200 China next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 201 China NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 202 China NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 203 China next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 204 India next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 205 India next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 206 India next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 207 India next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 208 India NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 209 India NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 210 India next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 211 India next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 212 India targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 213 India next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 214 India NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 215 India NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 216 India next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 217 South Korea next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 218 South Korea next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 219 South Korea next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 220 South Korea next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 221 South Korea NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 222 South Korea NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 223 South Korea next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 224 South Korea next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 225 South Korea targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 226 South Korea next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 227 South Korea NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 228 South Korea NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 229 South Korea next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 230 Australia next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 231 Australia next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 232 Australia next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 233 Australia next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 234 Australia NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 235 Australia NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 236 Australia next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 237 Australia next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 238 Australia targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 239 Australia next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 240 Australia NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 241 Australia NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 242 Australia next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 243 Thailand next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 244 Thailand next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 245 Thailand next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 246 Thailand next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 247 Thailand NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 248 Thailand NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 249 Thailand next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 250 Thailand next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 251 Thailand targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 252 Thailand next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 253 Thailand NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 254 Thailand NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 255 Thailand next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 256 Latin America next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 257 Latin America next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 258 Latin America next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 259 Latin America next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 260 Latin America NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 261 Latin America NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 262 Latin America next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 263 Latin America next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 264 Latin America targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 265 Latin America next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 266 Latin America NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 267 Latin America NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 268 Latin America next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 269 Brazil next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 270 Brazil next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 次世代シーケンシング(NGS)の世界市場2024年-2030年:市場規模、シェア、動向分析(Next Generation Sequencing Market Size, Share & Trends Analysis Report By Technology (WGS, Targeted Sequencing & Resequencing), By Product (Platform, Consumables), By Application, By Workflow, By End-use, By Region, And Segment Forecasts, 2024 - 2030)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆